CDLX
Cardlytics, Inc.1.0600
+0.0200+1.92%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Q&A details BofA impact, recovery steps
Q&A pinned Q1 billings weakness mostly on BofA's January 15 exit, with content restrictions secondary but easing toward last summer's levels by year-end. Management detailed sequential growth via new bank portfolios and UI boosts, plus tech gains from ditching BofA's parallel stack. Grocery/gas grew 21% YoY and restaurant delivery 13% YoY, while subscription softened on restrictions—new formats eyed. Bridg proceeds to quickly delever via PAR stock sale; SKU targeting shelved post-sale. Q2 positive EBITDA now in sight. Confident tone pervades; investors track network rebound.
Key Stats
Market Cap
57.30MP/E (TTM)
-Basic EPS (TTM)
-2.06Dividend Yield
0%Recent Filings
8-K
8-K
Q4 revenue drops, EBITDA improves
Cardlytics reported Q4 2025 revenue of $56.1M, down 24.2% from $74.0M last year, while Adjusted EBITDA swung to $8.5M from $6.4M. Full-year revenue fell 16.2% to $233.3M, but net loss narrowed to $103.5M from $189.3M amid cost cuts. MQUs rose 18.4% to 227M, yet ACPU plunged 35.0% to $0.12. Q1 2026 guides Billings $57.5-$63.5M, down 35-41%. Bank of America campaigns ended.
10-K
FY2025 results
Cardlytics posted FY2025 revenue of $233M, down 16% y/y from $278M, with billings off 13% to $385M amid Bank of America non-renewal and softer advertiser spend; Q4 showed sequential stabilization as Cardlytics MQUs climbed 18% y/y to 224K average while ACPU fell 25% to $0.50 (derived). Adjusted EBITDA swung positive to $10M from $3M, fueled by $3.8M restructuring and $5.3M ERC credits, yet $49M U.S. goodwill impairment reflected macro headwinds. Year-end debt stood at $213M including $173M 4.25% notes due 2029; $40M revolver drawn with $8M available. Bridg sale to PAR affiliate pending for up to $30M in stock. Quarterly results volatile; Bank of America exit threatens momentum.
8-K
Sells Bridg to PAR for stock
Cardlytics signed an asset purchase agreement on January 23, 2026, to sell its Bridg platform assets to PAR Technology's subsidiary for up to $30M in PAR common stock, calculated via VWAP over 15 trading days pre-closing. Closing awaits customary conditions like no material adverse effects, with termination possible by March 24, 2026. PAR commits to registering the shares promptly. Deal sharpens Cardlytics' focus.
8-K
CFO Evans appointed Jan 2026
Cardlytics appointed David Evans as CFO effective January 12, 2026, replacing Alexis DeSieno, who transitions to advisor through March 6. Evans, a company alum from 2014-2020, returns with $400,000 salary, 100% bonus target, $200,000 signing bonus, and 1,000,000 RSUs vesting over two years. Evans knows Cardlytics cold. This bolsters finance leadership amid turnaround efforts.
IPO
Website
Employees
Sector
Industry
ADV
Advantage Solutions Inc.
0.84-0.00
DRCT
Direct Digital Holdings, Inc.
0.07-0.00
FLNT
Fluent, Inc.
2.06-0.07
ILLMF
illumin Holdings Inc.
0.71+0.01
NEXN
Nexxen International Ltd.
6.74-0.05
SABOF
Sabio Holdings Inc.
0.15+0.00
SPTY
Specificity, Inc.
0.14+0.01
STGW
Stagwell Inc.
5.52-0.04
TGNT
Totaligent Inc.
0.02-0.01
TTD
The Trade Desk, Inc.
36.64+0.45